Short- and long-term effects of felodipine on circulating endothelin and atrial natriuretic peptide levels in essential hypertension. 1993

B Erbas, and O Ozdemir, and I Pasaoglu, and O Ugur, and E Varoglu, and Z Koray, and C Yorgancioglu, and E Hazan, and E Oram, and C F Bekdik

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

B Erbas, and O Ozdemir, and I Pasaoglu, and O Ugur, and E Varoglu, and Z Koray, and C Yorgancioglu, and E Hazan, and E Oram, and C F Bekdik
January 1986, Lancet (London, England),
B Erbas, and O Ozdemir, and I Pasaoglu, and O Ugur, and E Varoglu, and Z Koray, and C Yorgancioglu, and E Hazan, and E Oram, and C F Bekdik
May 1987, American heart journal,
B Erbas, and O Ozdemir, and I Pasaoglu, and O Ugur, and E Varoglu, and Z Koray, and C Yorgancioglu, and E Hazan, and E Oram, and C F Bekdik
January 1987, Drugs,
B Erbas, and O Ozdemir, and I Pasaoglu, and O Ugur, and E Varoglu, and Z Koray, and C Yorgancioglu, and E Hazan, and E Oram, and C F Bekdik
January 1985, Hypertension (Dallas, Tex. : 1979),
B Erbas, and O Ozdemir, and I Pasaoglu, and O Ugur, and E Varoglu, and Z Koray, and C Yorgancioglu, and E Hazan, and E Oram, and C F Bekdik
September 1988, Kidney international. Supplement,
B Erbas, and O Ozdemir, and I Pasaoglu, and O Ugur, and E Varoglu, and Z Koray, and C Yorgancioglu, and E Hazan, and E Oram, and C F Bekdik
October 1986, The Journal of clinical endocrinology and metabolism,
B Erbas, and O Ozdemir, and I Pasaoglu, and O Ugur, and E Varoglu, and Z Koray, and C Yorgancioglu, and E Hazan, and E Oram, and C F Bekdik
September 1987, Mayo Clinic proceedings,
B Erbas, and O Ozdemir, and I Pasaoglu, and O Ugur, and E Varoglu, and Z Koray, and C Yorgancioglu, and E Hazan, and E Oram, and C F Bekdik
October 1987, Journal of hypertension,
B Erbas, and O Ozdemir, and I Pasaoglu, and O Ugur, and E Varoglu, and Z Koray, and C Yorgancioglu, and E Hazan, and E Oram, and C F Bekdik
March 1991, Journal of clinical pharmacology,
B Erbas, and O Ozdemir, and I Pasaoglu, and O Ugur, and E Varoglu, and Z Koray, and C Yorgancioglu, and E Hazan, and E Oram, and C F Bekdik
January 2009, Clinical laboratory,
Copied contents to your clipboard!